| Derek Lloyd Schwaiger, PT, DPT | |
|
1351 Fowler St Ste 110, Richland, WA 99352-4714 | |
| (509) 942-2574 | |
| (509) 942-2575 |
| Full Name | Derek Lloyd Schwaiger |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 1351 Fowler St Ste 110, Richland, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609429661 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PT60932359 (Washington) | Secondary |
| 225100000X | Physical Therapist | PT60932359 (Washington) | Primary |
| Entity Name | Kadlec Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972507580 PECOS PAC ID: 9739098617 Enrollment ID: O20031104000035 |
News Archive
AstraZeneca and Targacept, Inc. today announced top-line results from the first of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
Using the tools and techniques of soft condensed matter physics, a research team in Switzerland has demonstrated that a finely tuned balance of attractions between proteins keeps the lens of the eye transparent, and that even a small change in this balance can cause proteins to aggregate and de-mix.
Brain surgery is famously difficult for good reason: When removing a tumor, for example, neurosurgeons walk a tightrope as they try to take out as much of the cancer as possible while keeping crucial brain tissue intact — and visually distinguishing the two is often impossible.
Wolbachia bacteria are widely studied for possible properties to block transmission of viruses like chikungunya, dengue and zika.
Cameron Health, Inc., a pioneer in the development, manufacture and distribution of next generation implantable cardioverter defibrillators (ICDs), announced today that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel voted 7-1 that sufficient data exists demonstrating the efficacy and safety of the S-ICD System for the treatment of sudden cardiac arrest (SCA).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derek Lloyd Schwaiger, PT, DPT 550 Gage Blvd Ste 101, Richland, WA 99352-9532 Ph: (509) 942-3627 | Derek Lloyd Schwaiger, PT, DPT 1351 Fowler St Ste 110, Richland, WA 99352-4714 Ph: (509) 942-2574 |
News Archive
AstraZeneca and Targacept, Inc. today announced top-line results from the first of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
Using the tools and techniques of soft condensed matter physics, a research team in Switzerland has demonstrated that a finely tuned balance of attractions between proteins keeps the lens of the eye transparent, and that even a small change in this balance can cause proteins to aggregate and de-mix.
Brain surgery is famously difficult for good reason: When removing a tumor, for example, neurosurgeons walk a tightrope as they try to take out as much of the cancer as possible while keeping crucial brain tissue intact — and visually distinguishing the two is often impossible.
Wolbachia bacteria are widely studied for possible properties to block transmission of viruses like chikungunya, dengue and zika.
Cameron Health, Inc., a pioneer in the development, manufacture and distribution of next generation implantable cardioverter defibrillators (ICDs), announced today that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel voted 7-1 that sufficient data exists demonstrating the efficacy and safety of the S-ICD System for the treatment of sudden cardiac arrest (SCA).
› Verified 8 days ago